MedWellAI (MWAI)
OTHER OTC:MWAI
Want to see MWAI full AI Analyst Report?
MWAI Stock Chart & Stats
$0.72
--
Market closed
$0.72
--
Day’s Range― - ―
52-Week Range$0.20 - $0.80
Previous CloseN/A
VolumeN/A
Average Volume (3M)4.51K
Market Cap
$1.70M
Enterprise Value$2.53M
Total Cash (Recent Filing)$223.22K
Total Debt (Recent Filing)$600.30K
Price to Earnings (P/E)―
Beta0.67
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.36
Shares Outstanding6,536,580
10 Day Avg. Volume2,376
30 Day Avg. Volume4,515
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.81
Price to Sales (P/S)3.42
P/FCF Ratio-2.17
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue3.67
Enterprise Value/Gross Profit4.33
Enterprise Value/Ebitda-0.96
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Recurring SaaS Revenue Model In HealthcareA subscription-based SaaS model with implementation and support revenue creates durable, recurring cash inflows and sticky customer relationships with hospitals and clinics. Over 2–6 months this supports predictable revenue streams, upsell opportunities, and long-term customer lifetime value if client retention holds.
Low Nominal Debt BurdenModest stated debt keeps interest and mandatory cash outflows low, preserving near-term financial flexibility. Given ongoing losses, low nominal debt reduces refinancing pressure and supports the ability to raise equity or preferred capital without immediate debt-servicing constraints.
Expanded Preferred Stock Capacity For FinancingIncreasing Series B preferred authorization is a structural move to improve capital-raising flexibility, enabling non-debt funding that can be structured to preserve cash. Over coming months this can help bridge cash shortfalls and fund product or sales investments without adding traditional leverage.
Bears Say
Negative Shareholder Equity And Shrinking Asset BaseNegative equity and a shrinking balance sheet indicate accumulated losses and weaken the company’s solvency profile, restricting access to conventional financing and raising bankruptcy risk if losses continue. This structural weakness undermines long-term investment capacity and creditor confidence.
Persistent Operating And Free Cash Flow DeficitsOngoing negative operating and free cash flow signal structural cash burn and dependence on external capital to fund operations. This limits strategic options, forces dilution or borrowing, and constrains the company’s ability to sustainably invest in product development and sales until cash generation turns positive.
Highly Volatile Revenue With Sharp 2025 DeclineA dramatic, persistent top-line decline undermines scalability and the ability to cover fixed costs; it also questions product-market fit and sales execution. Such volatility makes multi-month planning difficult, stresses margins, and raises uncertainty about sustainable demand for core AI products.
MedWellAI News
MWAI FAQ
What was MedWellAI’s price range in the past 12 months?
MedWellAI lowest stock price was $0.20 and its highest was $0.80 in the past 12 months.
What is MedWellAI’s market cap?
MedWellAI’s market cap is $1.70M.
When is MedWellAI’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MedWellAI’s earnings last quarter?
MedWellAI released its earnings results on Feb 18, 2025. The company reported -$0.127 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.127.
Is MedWellAI overvalued?
According to Wall Street analysts MedWellAI’s price is currently Overvalued.
Does MedWellAI pay dividends?
MedWellAI does not currently pay dividends.
What is MedWellAI’s EPS estimate?
MedWellAI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MedWellAI have?
MedWellAI has 6,536,580 shares outstanding.
What happened to MedWellAI’s price movement after its last earnings report?
MedWellAI reported an EPS of -$0.127 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of MedWellAI?
Currently, no hedge funds are holding shares in MWAI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
MedWellAI
Based in Clearwater, Florida, MedWellAI Inc. (which rebranded from Integrated Ventures, Inc. in June 2025) operates through its subsidiary to cultivate, acquire, manage, and fund diverse businesses. The company primarily specializes in offering artificial intelligence-powered solutions for the health and wellness industry. Furthermore, MedWellAI facilitates the medical community by running a business-to-business online platform for distributing pharmaceutical goods, with a particular emphasis on GLP-1 medications designed for weight management and diabetes care. This is augmented by an intelligent, AI-driven ordering system that provides functionalities like accurate inventory tracking and insightful recommendations, catering to various healthcare providers such as wellness centers, med spas, and corporate health programs.
Technical Analysis
Nvni Group
―
Xiao-I Corp. ADR
―
Simpple Ltd.
―
Health In Tech, Inc. Class A
―
Cloudastructure, Inc. Class A
―